Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HOFFMANN-LA ROCHE INC. v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
2:11-cv-03635
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 02, 2012
Judge Mulls Stay In Roche's Xeloda Patent Suit Against Teva
A New Jersey federal judge on Thursday said she was inclined to stay Hoffman-La Roche Inc.'s patent infringement action against Teva Pharmaceuticals USA Inc. over chemotherapy drug Xeloda based on the dismissal of an earlier case and its pending appeal.
-
June 28, 2011
Roche Files 3 Patent Suits Over Generic Xeloda
Hoffmann-La Roche Inc. sued Intas Pharmaceuticals Ltd. on Friday in an effort to protect the market for the cancer drug Xeloda, marking the third patent suit over Xeloda that Roche filed in New Jersey federal court last week.